RSLAX
Price
$55.75
Change
-$0.92 (-1.62%)
Updated
Sep 6 closing price
RSLDX
Price
$67.11
Change
-$1.11 (-1.63%)
Updated
Sep 6 closing price
Ad is loading...

RSLAX vs RSLDX

Header iconRSLAX vs RSLDX Comparison
Open Charts RSLAX vs RSLDXBanner chart's image
American Funds SMALLCAP World R1
Price$55.75
Change-$0.92 (-1.62%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World R5E
Price$67.11
Change-$1.11 (-1.63%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RSLAX vs RSLDX Comparison Chart
Loading...
VS
RSLAX vs. RSLDX commentary
Sep 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSLAX is a StrongSell and RSLDX is a StrongSell.

FUNDAMENTALS
Fundamentals
RSLAX (72.2B) and RSLDX (72.2B) have equal amount of cash in the bank . RSLDX pays higher dividends than RSLAX: RSLDX (0.83) vs RSLAX (0.35). RSLAX was incepted earlier than RSLDX: RSLAX (22 years) vs RSLDX (9 years). RSLAX (29.00) and RSLDX (29.00) have comparable annual turnover. RSLAX (250) and RSLDX (250) have matching initial minimum investment requirements. RSLDX annual gain was more profitable for investors over the last year : 9.97 vs. RSLAX (8.94). RSLDX return over 5 years is better than : 22.10 vs. RSLAX (13.91).
RSLAXRSLDXRSLAX / RSLDX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years9 years-
Gain YTD1.2511.89766%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets72.2B72.2B100%
Annual Yield % from dividends0.350.8342%
Returns for 1 year8.949.9790%
Returns for 3 years-30.25-27.25111%
Returns for 5 years13.9122.1063%
Returns for 10 years19.24N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNOB25.001.03
+4.30%
ConnectOne Bancorp
DORM110.430.77
+0.70%
Dorman Products
LVO1.59-0.01
-0.62%
LiveOne
NICE162.26-3.25
-1.96%
NICE Ltd
BGLC0.42-0.01
-2.43%
BioNexus Gene Lab Corp